L L Ng

Summary

Affiliation: University of Leicester
Country: UK

Publications

  1. ncbi Biomarkers in acute myocardial infarction
    Daniel Chan
    Leicester National Institute for Health Research Cardiovascular Biomedical Research Unit, UK
    BMC Med 8:34. 2010
  2. ncbi Plasma urotensin in human systolic heart failure
    Leong L Ng
    Department of Medicine and Therapeutics, University of Leicester, Leicester, UK
    Circulation 106:2877-80. 2002
  3. ncbi Diagnosis of heart failure using urinary natriuretic peptides
    L L Ng
    University of Leicester, Department of Cardiovascular Sciences, Clinical Sciences Building, Leicester Royal Infirmary, Leicester LE2 7LX, U K
    Clin Sci (Lond) 106:129-33. 2004
  4. ncbi Augmentation of the neutrophil respiratory burst through the action of advanced glycation end products: a potential contributor to vascular oxidant stress
    Richard K M Wong
    Division of Medicine and Therapeutics, University of Leicester, Leicester, U K
    Diabetes 51:2846-53. 2002
  5. ncbi Plasma urocortin in human systolic heart failure
    Leong L Ng
    University of Leicester Department of Cardiovascular Sciences, Clinical Sciences Building, Leicester Royal Infirmary, Leicester LE2 7LX, U K
    Clin Sci (Lond) 106:383-8. 2004
  6. ncbi Identification of previously undiagnosed left ventricular systolic dysfunction: community screening using natriuretic peptides and electrocardiography
    Leong L Ng
    Department of Medicine and Therapeutics, Robert Kilpatrick, Clinical Sciences Building, Leicester Royal Infirmary, Leicester LE2 7LX, UK
    Eur J Heart Fail 5:775-82. 2003
  7. ncbi Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptides
    Leong L Ng
    Department of Cardiovascular Sciences, University of Leicester, Clinical Sciences Building, Leicester Royal Infirmary, Leicester LE2 7LX, United Kingdom
    J Am Coll Cardiol 45:1043-50. 2005
  8. ncbi Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure
    Leong L Ng
    Department of Cardiovascular Sciences, University of Leicester, UK
    Am Heart J 152:94-101. 2006
  9. ncbi Oxygen-regulated protein 150 and prognosis following myocardial infarction
    Leong L Ng
    Pharmacology and Therapeutics Group, Department of Cardiovascular Sciences, University of Leicester, Robert Kilpatrick Clinical Sciences Building, Leicester Royal Infirmary, Leicester, UK
    Clin Sci (Lond) 112:477-84. 2007
  10. ncbi Proteinase 3 and prognosis of patients with acute myocardial infarction
    Leong L Ng
    Department of Cardiovascular Sciences, University of Leicester, Leicester LE2 7LX, UK
    Clin Sci (Lond) 120:231-8. 2011

Collaborators

Detail Information

Publications73

  1. ncbi Biomarkers in acute myocardial infarction
    Daniel Chan
    Leicester National Institute for Health Research Cardiovascular Biomedical Research Unit, UK
    BMC Med 8:34. 2010
    ..Randomised trials are urgently needed to address this translational gap before the use of novel biomarkers becomes common practice to facilitate tailored treatment following an acute coronary event...
  2. ncbi Plasma urotensin in human systolic heart failure
    Leong L Ng
    Department of Medicine and Therapeutics, University of Leicester, Leicester, UK
    Circulation 106:2877-80. 2002
    ..We investigated plasma UTN levels in heart failure (HF; left ventricular systolic dysfunction) in comparison with plasma N-terminal pro-brain natriuretic peptide (N-BNP) levels...
  3. ncbi Diagnosis of heart failure using urinary natriuretic peptides
    L L Ng
    University of Leicester, Department of Cardiovascular Sciences, Clinical Sciences Building, Leicester Royal Infirmary, Leicester LE2 7LX, U K
    Clin Sci (Lond) 106:129-33. 2004
    ..Use of urinary N-BNP for heart failure diagnosis may be suitable for high-throughput screening, especially in subjects reluctant to provide blood samples...
  4. ncbi Augmentation of the neutrophil respiratory burst through the action of advanced glycation end products: a potential contributor to vascular oxidant stress
    Richard K M Wong
    Division of Medicine and Therapeutics, University of Leicester, Leicester, U K
    Diabetes 51:2846-53. 2002
    ....
  5. ncbi Plasma urocortin in human systolic heart failure
    Leong L Ng
    University of Leicester Department of Cardiovascular Sciences, Clinical Sciences Building, Leicester Royal Infirmary, Leicester LE2 7LX, U K
    Clin Sci (Lond) 106:383-8. 2004
    ..Its decline with increasing HF severity may expedite disease progression due to diminished cardioprotective/anti-inflammatory effects. UCN measurement may also complement N-BNP in the diagnosis of early HF...
  6. ncbi Identification of previously undiagnosed left ventricular systolic dysfunction: community screening using natriuretic peptides and electrocardiography
    Leong L Ng
    Department of Medicine and Therapeutics, Robert Kilpatrick, Clinical Sciences Building, Leicester Royal Infirmary, Leicester LE2 7LX, UK
    Eur J Heart Fail 5:775-82. 2003
    ..We examined strategies to improve the positive predictive value of natriuretic peptides in screening for undiagnosed left ventricular systolic dysfunction (LVSD) in the community...
  7. ncbi Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptides
    Leong L Ng
    Department of Cardiovascular Sciences, University of Leicester, Clinical Sciences Building, Leicester Royal Infirmary, Leicester LE2 7LX, United Kingdom
    J Am Coll Cardiol 45:1043-50. 2005
    ..We sought to compare urinary and plasma N-terminal pro-brain natriuretic peptide (N-BNP) in left ventricular systolic dysfunction (LVSD) diagnosis...
  8. ncbi Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure
    Leong L Ng
    Department of Cardiovascular Sciences, University of Leicester, UK
    Am Heart J 152:94-101. 2006
    ..We sought to improve specificity using inflammatory markers such as C-reactive protein (CRP) and myeloperoxidase (MPO), which have been implicated in cardiovascular disease...
  9. ncbi Oxygen-regulated protein 150 and prognosis following myocardial infarction
    Leong L Ng
    Pharmacology and Therapeutics Group, Department of Cardiovascular Sciences, University of Leicester, Robert Kilpatrick Clinical Sciences Building, Leicester Royal Infirmary, Leicester, UK
    Clin Sci (Lond) 112:477-84. 2007
    ..In conclusion, ORP150 and peptide fragments derived from it are secreted following AMI and provide independent prognostic information on mortality. High levels associated with endoplasmic reticulum/hypoxic stress predict a poor outcome...
  10. ncbi Proteinase 3 and prognosis of patients with acute myocardial infarction
    Leong L Ng
    Department of Cardiovascular Sciences, University of Leicester, Leicester LE2 7LX, UK
    Clin Sci (Lond) 120:231-8. 2011
    ..PR3 may represent a clinically useful marker of prognosis after an AMI as part of a multimarker strategy...
  11. ncbi Red cell Na+/Li+ countertransport and Na+/H+ exchanger isoforms in human proximal tubules
    L L Ng
    Department of Medicine, Leicester Royal Infirmary, England, United Kingdom
    Kidney Int 58:229-35. 2000
    ....
  12. ncbi Na+/H+ exchanger activity and phosphorylation in temperature-sensitive immortalized proximal tubule cell lines derived from the spontaneously hypertensive rat
    L L Ng
    Department of Medicine and Therapeutics, Clinical Sciences Building, Leicester Royal Infirmary, Leicester LE2 7LX, U K
    Clin Sci (Lond) 98:409-18. 2000
    ..These cell lines form a useful model for defining the biochemical mechanisms leading to the NHE-1 phenotype in the SHR kidney, in addition to investigations of other SHR phenotypic markers...
  13. ncbi Non-competitive immunochemiluminometric assay for cardiotrophin-1 detects elevated plasma levels in human heart failure
    Leong L Ng
    Department of Medicine and Therapeutics, Clinical Sciences Building, Leicester Royal Infirmary, Leicester LE2 7LX, U K
    Clin Sci (Lond) 102:411-6. 2002
    ....
  14. ncbi Cardiotrophin-1 predicts death or heart failure following acute myocardial infarction
    Sohail Q Khan
    Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom
    J Card Fail 12:635-40. 2006
    ..84 (95% CI: 0.78-0.91, P < .001). CONCLUSION: After an AMI, combined levels of CT-1 and NT-proBNP are more informative at predicting death or heart failure than either marker alone...
  15. ncbi C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study
    Sohail Q Khan
    University of Leicester, Department of Cardiovascular Sciences, Leicester Royal Infirmary, Leicester LE2 7LX, UK
    Circulation 115:2103-10. 2007
    ..We compared the prognostic value of copeptin and an established marker, N-terminal pro-B-type natriuretic peptide (NTproBNP), after acute myocardial infarction...
  16. ncbi Prolonged stability of endogenous cardiotrophin-1 in whole blood
    P F Downie
    Department of Medicine and Therapeutics, University of Leicester, UK
    Metabolism 50:237-40. 2001
    ....
  17. ncbi Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis
    S Talwar
    Department of Medicine and Therapeutics, University of Leicester, Leicester, UK
    Eur J Heart Fail 3:15-9. 2001
    ..These markers may also be useful to identify the optimum time for surgery in AS...
  18. ncbi Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction
    Iain B Squire
    Department of Medicine and Therapeutics, University of Leicester, Leicester, United Kingdom
    J Card Fail 10:328-33. 2004
    ..Higher left ventricular volumes are associated with lower plasma MMP-2 concentrations. Circulating MMP concentrations may provide insights into left ventricular remodeling after acute myocardial infarction...
  19. ncbi Matrix metalloproteinase-2 predicts mortality in patients with acute coronary syndrome
    Onkar S Dhillon
    Department of Cardiovascular Sciences, Clinical Sciences Building, Leicester Royal Infirmary, Leicester LE2 7LX, UK
    Clin Sci (Lond) 118:249-57. 2010
    ....
  20. ncbi N-terminal pro-B-type natriuretic peptide is better than TIMI risk score at predicting death after acute myocardial infarction
    S Q Khan
    University of Leicester, Department of Cardiovascular Sciences, Leicester Royal Infirmary, Leicester, UK
    Heart 94:40-3. 2008
    ..N-terminal pro-B-type natriuretic peptide (NTproBNP) has also been found to be useful in predicting mortality following STEMI...
  21. ncbi Leucocyte intracellular pH and Na+/H+ exchanger isoform-1 activity in postpartum women with pre-eclampsia
    V M Lee
    Department of Medicine and Therapeutics, Leicester Royal Infirmary, UK
    BJOG 108:615-22. 2001
    ..This increased activity is not due to an increase in exchanger isoform-1 protein abundance or the presence of exchanger isoform-3...
  22. ncbi Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF
    Iain B Squire
    Department of Medicine and Therapeutics, University of Leicester, Clinical Sciences Building, Leicester Royal Infirmary, LE2 7LX, Leicester, UK
    Eur J Heart Fail 5:499-506. 2003
    ..79 cf 0.66), LVF hospitalisation (0.78 cf 0.70) or heart failure as an outpatient (0.71 cf 0.61). CONCLUSIONS: Plasma NT-proBNP measured pre-discharge provides useful prognostic information following hospitalisation with acute LVF...
  23. ncbi Neutrophil activation and production of reactive oxygen species in pre-eclampsia
    Virginia M Lee
    University of Leicester, The Division of Medicien and Therapeutics, Leicester Royal Infirmary, UK
    J Hypertens 21:395-402. 2003
    ..Increased ROS production in pre-eclampsia may highlight a role for neutrophils in the oxidative stress and associated endothelial dysfunction that are characteristic of the condition...
  24. ncbi Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate
    Ian Loke
    Department of Medicine and Therapeutics, Clinical Sciences Building, University of Leicester, Leicester Royal Infirmary, Leicester LE2 7LX, UK
    Eur J Heart Fail 5:599-606. 2003
    ..In constructing normal ranges for diagnostic use, covariates such as age and gender must be considered, in addition to the format of assay being used...
  25. ncbi Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy
    Iain B Squire
    University of Leicester Department of Cardiovascular Sciences, Leicester, United Kingdom
    J Card Fail 11:492-7. 2005
    ..026) had independent predictive value for death after 30 days. CONCLUSION: N-ANP, BNP, N-BNP, and CNP show distinct plasma profiles after AMI. Failure of plasma N-BNP to fall in the 30 days after AMI indicates adverse prognosis...
  26. ncbi Potassium and activity of the sodium hydrogen exchanger isoform 1 in vascular smooth muscle of hypertensive rats
    P A Quinn
    Department of Medicine and Therapeutics, University of Leicester, Leicester, UK
    Metabolism 50:778-82. 2001
    ..This response of NHE-1 in SHR VSMCs to K(+) depletion indicated a direct effect on these cells and could potentially enhance the contractile or proliferative phenotype of these cells in vivo...
  27. ncbi Plasma cardiotrophin-1 following acute myocardial infarction: relationship with left ventricular systolic dysfunction
    Suneel Talwar
    Department of Medicine and Therapeutics, University of Leicester, Robert Kilpatrick Clinical Sciences Building, Leicester Royal Infirmary, Leicester LE2 7LX, U.K
    Clin Sci (Lond) 102:9-14. 2002
    ..CT-1 measured soon after AMI is indicative of LV dysfunction, and this cytokine may have a role in the development of ventricular remodelling and heart failure after AMI...
  28. ncbi Stimulated mitogen-activated protein kinase is necessary but not sufficient for the mitogenic response to angiotensin II. A role for phospholipase D
    N Wilkie
    Department of Cell Physiology and Pharmacology, University of Leicester, Medical Sciences Building, P O Box 138, University Road, Leicester LE1 9HN, United Kingdom
    J Biol Chem 271:32447-53. 1996
    ....
  29. ncbi Inhibition of the respiratory burst by resveratrol in human monocytes: correlation with inhibition of PI3K signaling
    Toryn M Poolman
    Pharmacology and Therapeutics Group, Department of Cardiovascular Sciences, University of Leicester, Clinical Sciences Building, Leicester Royal Infirmary, UK
    Free Radic Biol Med 39:118-32. 2005
    ..Other known inhibitors of both PI3K and Akt were also found to inhibit this response. Therefore, inhibition of signaling through the PI3K to NADPH oxidase by t-RVT might represent an important anti-inflammatory mechanism...
  30. ncbi Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study
    Sohail Q Khan
    University of Leicester, Department of Cardiovascular Sciences, Leicester Royal Infirmary, Leicester, United Kingdom
    J Am Coll Cardiol 49:1525-32. 2007
    ..This study sought to assess the prognostic impact of midregional pro-adrenomedullin (MR-proADM) after an acute myocardial infarction (AMI)...
  31. ncbi Myotrophin is a more powerful predictor of major adverse cardiac events following acute coronary syndrome than N-terminal pro-B-type natriuretic peptide
    Sohail Q Khan
    Department of Cardiovascular Sciences, University of Leicester, Clinical Sciences Building, Leicester Royal Infirmary, Leicester LE2 7LX, UK
    Clin Sci (Lond) 112:251-6. 2007
    ..63; P=0.006). In conclusion, after an ACS, levels of myotrophin are more informative at predicting MACE than NTproBNP and may be useful to risk stratify patients...
  32. ncbi Urotensin II is raised in acute myocardial infarction and low levels predict risk of adverse clinical outcome in humans
    Sohail Q Khan
    University of Leicester, Department of Cardiovascular Sciences, Clinical Sciences Building, Leicester Royal Infirmary, Leicester LE2 7LX, UK
    Int J Cardiol 117:323-8. 2007
    ..We also compared UII to N terminal pro B type natriuretic peptide (NT-BNP) to evaluate whether levels of UII can be used to predict the risk of adverse clinical outcome (ACO)...
  33. ncbi Improving the diagnostic accuracy of N-terminal B-type natriuretic peptide in human systolic heart failure by plasma profiling using mass spectrometry
    Donald J L Jones
    Cancer Biomarkers and Prevention Group, Biocentre, University of Leicester, UK
    J Proteome Res 6:3329-34. 2007
    ..The accuracy of SHF diagnosis using NTproBNP is improved by the use of a plasma profile of 6 peptide peaks, reducing the uncertainty in the diagnostic gray zone of using NTproBNP alone...
  34. ncbi Natriuretic peptides in common valvular heart disease
    Christopher D Steadman
    Department of Cardiovascular Sciences, University Hospitals of Leicester, Leicester, UK
    J Am Coll Cardiol 55:2034-48. 2010
    ....
  35. ncbi N-terminal pro-B-type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome
    Sohail Q Khan
    Department of Cardiovascular Sciences, University of Leicester, Leicester Royal Infirmary, Leicester, UK
    Clin Sci (Lond) 117:31-9. 2009
    ..85] and 6-month mortality (AUC, 0.81). NT-proBNP gives complementary information to the GRACE risk score for predicting early and late mortality. The inclusion of the NT-proBNP blood test is useful in risk-stratifying patients after ACS...
  36. ncbi Advanced glycation end products stimulate an enhanced neutrophil respiratory burst mediated through the activation of cytosolic phospholipase A2 and generation of arachidonic Acid
    Richard K M Wong
    Division of Medicine and Therapeutics, University of Leicester, Leicester Royal Infirmary, Leicester, UK
    Circulation 108:1858-64. 2003
    ..AA is generated by cPLA2, which may be stimulated through an AGE-activated redox-sensitive pathway...
  37. ncbi Usefulness of plasma tissue inhibitors of metalloproteinases as markers of prognosis after acute myocardial infarction
    Dominic Kelly
    Department of Cardiovascular Sciences, University of Leicester, Leicester, UK
    Am J Cardiol 106:477-82. 2010
    ..001 for all comparisons, log-rank test). In conclusion, higher plasma TIMP-1, -2, and -4 after AMI are associated with MACEs and provide additional prognostic information to that obtained from GRACE clinical risk scores alone...
  38. ncbi Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction
    Sohail Q Khan
    Department of Cardiovascular Sciences, University of Leicester, Clinical Sciences Building, Leicester Royal Infirmary, Leicester LE2 7LX, UK
    Eur Heart J 30:1057-65. 2009
    ..We were interested to see if GDF-15 could provide long-term prognostic value in post-AMI patients. We compared GDF-15 with N-terminal pro-B-type natriuretic peptide (NT-proBNP)...
  39. ncbi Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study
    Sohail Q Khan
    University of Leicester, Department of Cardiovascular Sciences, Clinical Sciences Building, Leicester Royal Infirmary, Leicester, United Kingdom
    J Am Coll Cardiol 51:1857-64. 2008
    ..Our aim was to assess the prognostic value of midregional pro-atrial natriuretic peptide (MR-proANP) in patients after acute myocardial infarction (AMI)...
  40. ncbi N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction
    Iain B Squire
    Department of Medicine and Therapeutics, University of Leicester, Leicester Royal Infirmary, LE2 7LX, UK
    Clin Sci (Lond) 107:309-16. 2004
    ..Our results indicate that N-BNP predicts 30-day and N-ANP >30-day mortality. We conclude that consideration of both N-ANP and N-BNP identifies a greater number of patients at risk of death or heart failure than either peptide alone...
  41. ncbi C-terminal pro-endothelin-1 offers additional prognostic information in patients after acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) Study
    Sohail Q Khan
    Department of Cardiovascular Sciences, University of Leicester, Leicester Royal Infirmary, Leicester, UK
    Am Heart J 154:736-42. 2007
    ..We investigated the cardiovascular prognostic value post-AMI of CT-proET-1 and compared it to N-terminal pro-B-type natriuretic peptide (NTproBNP), a marker of death and HF...
  42. ncbi Prognostic value of mid-regional pro-adrenomedullin levels taken on admission and discharge in non-ST-elevation myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) II study
    Onkar S Dhillon
    Department of Cardiovascular Sciences, University of Leicester, Leicester Royal Infirmary, Leicester, United Kingdom
    J Am Coll Cardiol 56:125-33. 2010
    ..N-terminal pro-B-type natriuretic peptide and GRACE (Global Registry of Acute Coronary Events) score were used as comparators...
  43. ncbi Myeloperoxidase aids prognostication together with N-terminal pro-B-type natriuretic peptide in high-risk patients with acute ST elevation myocardial infarction
    Sohail Q Khan
    Department of Cardiovascular Medicine, University of Leicester, Clinical Sciences Building, Leicester Royal Infirmary, Leicester, UK
    Heart 93:826-31. 2007
    ..One such inflammatory marker is myeloperoxidase (MPO). Its role as a predictor of death or MI in patients with ST segment elevation myocardial infarction (STEMI) is unclear...
  44. ncbi Influence of confounding factors on plasma mid-regional pro-adrenomedullin and mid-regional pro-A-type natriuretic peptide concentrations in healthy individuals
    Sanjay S Bhandari
    Department of Cardiovascular Sciences, University of Leicester and NIHR Cardiovascular Biomedical Research Unit, Leicester, UK
    Biomarkers 16:281-7. 2011
    ..MRproADM and MRproANP can be used as diagnostic and prognostic markers in heart failure...
  45. ncbi Cardiotrophin-1 protects the human myocardium from ischemic injury. Comparison with the first and second window of protection by ischemic preconditioning
    S Ghosh
    Division of Cardiac Surgery, Department of Surgery, University of Leicester, Glenfield Hospital, LE3 9QP, Leicester, UK
    Cardiovasc Res 48:440-7. 2000
    ..We investigated the cardioprotective effects of CT-1 on the human myocardium and compared this benefit with the early and delayed protection afforded by ischemic preconditioning (PC)...
  46. ncbi Altered Na+/H+ exchanger isoform 1 activity in immortalized lymphoblasts from women with pre-eclampsia: evidence for an intermediate phenotype
    V M Lee
    University of Leicester, Division of Medicine and Therapeutics, Level 4, Clinical Sciences Building, Leicester Royal Infirmary, UK
    Clin Sci (Lond) 103:503-9. 2002
    ..Overactivity of the Na(+)/H(+) exchanger may contribute to the raised intracellular Na(+) concentration reported previously in white blood cells from women with pre-eclampsia...
  47. ncbi Myotrophin in human heart failure
    Ian Loke
    Department of Medicine and Therapeutics, University of Leicester, Leicester Royal Infirmary, Leicester, United Kingdom
    J Am Coll Cardiol 42:719-25. 2003
    ..This response is attenuated in more severe disease. The contribution of myotrophin to NFkappaB-mediated gene transcription and preservation of cardiac muscle mass remains to be investigated further...
  48. ncbi Procalcitonin as a prognostic marker in patients with acute myocardial infarction
    Dominic Kelly
    Department of Cardiovascular Sciences, University of Leicester, Leicester Royal Infirmary, Leicester, UK
    Biomarkers 15:325-31. 2010
    ..Procalcitonin is involved in the inflammatory response and is associated with adverse prognosis in certain conditions...
  49. ncbi Brain naturetic peptide (BNP) and diabetes mellitus
    L L Ng
    Department of Cardiovascular Sciences, University of Leicester, Leicester, UK
    Diabet Med 21:8-10. 2004
  50. ncbi Circulating stromelysin-1 (MMP-3): a novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction
    D Kelly
    Department of Cardiovascular Sciences, University of Leicester, UK
    Eur J Heart Fail 10:133-9. 2008
    ..We investigated the temporal profile of MMP-3 and its relationship to LV dysfunction and prognosis following AMI...
  51. ncbi Does cigarette smoking increase plasma urotensin II concentrations?
    S J Gold
    University Department of Cardiovascular Sciences, Pharmacology and Therapeutics Group, Division of Anaesthesia, Critical Care and Pain Management, Leicester Royal Infirmary, Leicester, LE1 5WW, UK
    Eur J Clin Pharmacol 63:253-7. 2007
    ..Our secondary aim was to compare the results obtained from assaying simultaneously using both radioimmunoassay (RIA) and immunoluminometric assay (ILMA)...
  52. ncbi Desensitisation of native and recombinant human urotensin-II receptors
    Madura S Batuwangala
    Division of Anaesthesia, Critical Care and Pain Management, University Department of Cardiovascular Sciences Pharmacology and Therapeutics Group, University of Leicester, Leicester, LE1 5WW, UK
    Naunyn Schmiedebergs Arch Pharmacol 380:451-7. 2009
    ..In summary, we report differences in the desensitisation profiles of native and recombinant U-II receptors. Design and interpretation of functional experiments are hampered by irreversibility of U-II binding...
  53. ncbi NADPH oxidase activity in preeclampsia with immortalized lymphoblasts used as models
    Virginia M Lee
    University of Leicester, Division of Medicine and Therapeutics, Level 4, Clinical Sciences Bldg, Leicester Royal Infirmary, Leicester, England
    Hypertension 41:925-31. 2003
    ..The enhancement of reactive oxygen species generation may be important in mediating the endothelial dysfunction seen in preeclampsia...
  54. ncbi C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction
    Dominic Kelly
    Department of Cardiovascular Sciences, University of Leicester, UK
    J Card Fail 14:739-45. 2008
    ..The aim of this study was to describe the association between Copeptin with LV dysfunction, volumes, and remodeling and clinical heart failure post-AMI...
  55. ncbi Gender and renal function influence plasma levels of copeptin in healthy individuals
    Sanjay S Bhandari
    Department of Cardiovascular Sciences, University of Leicester, Leicester LE2 7LX, U K
    Clin Sci (Lond) 116:257-63. 2009
    ..The present study suggests that gender and renal function specific partition values should be used to interpret copeptin values in future studies of this biomarker in HF or ischaemic heart disease...
  56. ncbi Searching for biomarkers of heart failure in the mass spectra of blood plasma
    Richard Willingale
    Department of Physics and Astronomy, University of Leicester, Leicester, UK
    Proteomics 6:5903-14. 2006
    ..Finally, a test dataset comprising a further 32 HF patients and 20 controls was used to verify that the 18 putative biomarkers and classification algorithms gave reliable predictions (accuracy 88.5%, ROC score 0.998)...
  57. ncbi The midregional portion of proadrenomedullin is an independent predictor of left ventricular mass index in hypertension
    Sanjay S Bhandari
    Departmet of Cardiovascular Sciences, University of Leicester, Leicester LE2 7LX, United Kingdom
    Metabolism 59:7-13. 2010
    ..Patients who test positive would necessitate echocardiography, enabling better resource allocation...
  58. ncbi Acute management of pregnancy associated cardiomyopathy with cardiac resynchronisation therapy
    Dominic Kelly
    Department of Cardiology, Glenfield Hospital, Groby Road, Leicester, LE3 9QP, United Kingdom
    Eur J Heart Fail 9:542-4. 2007
  59. ncbi A rat brain atlas of urotensin-II receptor expression and a review of central urotensin-II effects
    Benjamin D Hunt
    University Department of Cardiovascular Sciences Pharmacology and Therapeutics Group, Division of Anaesthesia, Critical Care and Pain Management, University of Leicester, Leicester Royal Infirmary, Leicester LE1 5WW, UK
    Naunyn Schmiedebergs Arch Pharmacol 382:1-31. 2010
    ..These predicted responses lend themselves to relatively simple experimental verification...
  60. ncbi Activation of a novel natriuretic endocrine system in humans with heart failure
    Hafid Narayan
    Department of Cardiovascular Sciences, University of Leicester, Clinical Sciences Building, Leicester Royal Infirmary, LeicesterLE2 7LX, UK
    Clin Sci (Lond) 118:367-74. 2010
    ..Elevated plasma proguanylin and prouroguanylin levels are associated with hypertension, renal impairment and increasing severity of HF. This novel endocrine system may contribute to the pathophysiology of HF...
  61. ncbi Cardiotropin-1 and myocardial strain change heterogeneously in cardiomyopathy
    D Dean Potter
    Division of Cardiovascular Surgery, University of Leicester, Leicester, United Kingdom
    J Surg Res 141:277-83. 2007
    ..The purpose of this study was to measure regional changes in cardiotrophin-1 (CT-1), a cytokine thought to play a role in LV remodeling, and regional changes in LV strain as measured with magnetic resonance imaging...
  62. ncbi Measurement of calcium and movement in heart cells
    Leong L Ng
    Department of Cardiovascular Diseases, Leicester Royal Infirmary, University of Leicester, UK
    Methods Mol Biol 312:261-8. 2006
  63. ncbi Neutrophil intracellular pH and Na+/H+ exchanger activity in pre-eclampsia
    Virginia M Lee
    Department of Medicine, Leicester Royal Infirmary, Leicester, UK
    Metabolism 52:87-93. 2003
    ..Intracellular pH may have been affected by plasma as shown in the time course experiments. DLF, an inhibitor of Na(+)/K(+)ATPase, may contribute to this intracellular acidosis in pre-eclamptic neutrophils...
  64. ncbi Augmented expression of cardiotrophin-1 in failing human hearts is accompanied by diminished glycoprotein 130 receptor protein abundance
    Oliver Zolk
    Institut fur Experimentelle und Klinische Pharmakologie und Toxikologie, Friedrich Alexander Universitat Erlangen Nurnberg, Erlangen, Germany
    Circulation 106:1442-6. 2002
    ..Although cardiac CT-1 gene expression is known to be upregulated in some animal models of congestive heart failure, the activation state of the CT-1 system in patients with congestive heart failure is unknown...
  65. ncbi Is plasma N-BNP a good indicator of the functional reserve of failing hearts? The FRESH-BNP study
    Simon G Williams
    Academic Unit of Molecular Vascular Medicine, University of Leeds, Martin Wing, Leeds General Infirmary, Leeds LS1 3EX, UK
    Eur J Heart Fail 6:891-900. 2004
    ....
  66. ncbi Comparison of plasma N-brain natriuretic peptide, peak oxygen consumption, and left ventricular ejection fraction for severity of chronic heart failure
    Simon G Williams
    Academic Unit of Molecular Vascular Medicine, University of Leeds, Leeds General Infirmary, Leeds, United Kingdom
    Am J Cardiol 93:1560-1. 2004
    ..001) and exercise duration (p = 0.001), whereas LVEF showed very poor correlations with peak VO(2) and exercise duration (both p >0.3). The results suggest that N-BNP actually reflects functional cardiac impairment better than LVEF...
  67. ncbi Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study
    Dominic Kelly
    Department of Vascular Surgery, St George s Hospital Medical School, London, UK
    Eur Heart J 28:711-8. 2007
    ....
  68. ncbi N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study
    Jonathan R Emberson
    Clinical Trial Service Unit, University of Oxford, UK
    J Am Coll Cardiol 49:311-9. 2007
    ..We sought to assess the ability of N-terminal pro-B-type natriuretic peptide (N-BNP) to predict vascular events in high-risk people and to test whether statins benefit people with high levels of N-BNP...
  69. ncbi Exercise duration and peak systolic blood pressure are predictive of mortality in ambulatory patients with mild-moderate chronic heart failure
    Simon G Williams
    Cardiac Transplant Unit, Wythenshawe Hospital, Manchester, UK
    Cardiology 104:221-6. 2005
    ..We sought to investigate whether exercise and haemodynamic parameters lack independent prognostic value in a cohort of unselected ambulatory patients with mild-moderate CHF...
  70. ncbi The cardioprotective agent urocortin induces expression of CT-1
    Sadia Janjua
    Institute of Child Health, University College London, London WC1N 1 EH, UK
    Cardiovasc Toxicol 3:255-62. 2003
    ..Hence, a specific cardioprotective factor can induce enhanced expression of another cardioprotective factor belonging to an unrelated protein family...
  71. ncbi Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial
    George Doukas
    Department of Cardiac Surgery, Glenfield Hospital, University Hospitals of Leicester NHS Trust, England
    JAMA 294:2323-9. 2005
    ....
  72. ncbi Increased free radical production in hypertension due to increased expression of the NADPH oxidase subunit p22(phox) in lymphoblast cell lines
    Andrew I Pettit
    Royal United Hospital Bath, Bath, UK
    J Hypertens 20:677-83. 2002
    ..To confirm increased production of reactive oxygen species (ROS) in hypertension, to demonstrate the source of ROS and to analyse NADPH oxidase subcomponent expression in hypertension...
  73. ncbi Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study
    Martin R Wilkins
    Experimental Medicine and Toxicology, Imperial College London, W12 0NN, UK
    Am J Respir Crit Care Med 171:1292-7. 2005
    ..Phosphodiesterase type 5 (PDE5) inhibition has been proposed for the treatment for pulmonary arterial hypertension (PAH)...